Data / Form D filings / ZS Pharma, Inc.
ZS Pharma, Inc.: Form D filings
ZS Pharma, Inc., a pharmaceuticals company in Coppell, TX, filed 8 Form D notices with the SEC between 2009 and 2014. The latest, on March 11, 2014, reports $25 million sold of a $25 million offering to 12 investors.
Find out what ZS Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 508 Wrangler Drive, Suite 100, Coppell, TX, 75019
- Phone
- (877) 700-0240
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1459266
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2014 | New notice | $25,000,000 | $25,000,000 | $0 | 12 | Feb 28, 2014 | sec.gov |
| Oct 23, 2012 | New notice | $46,000,000 | $27,600,001 | $18,399,999 | 6 | Oct 9, 2012 | sec.gov |
| Jul 10, 2012 | Amendment | $5,305,000 | $5,305,000 | $0 | 12 | Nov 10, 2011 | sec.gov |
| Dec 12, 2011 | Amendment | $4,305,000 | $4,305,000 | $0 | 12 | Nov 10, 2011 | sec.gov |
| Nov 22, 2011 | New notice | $4,305,000 | $3,930,000 | $375,000 | 12 | Nov 10, 2011 | sec.gov |
| Dec 20, 2010 | New notice | Indefinite | $792,000 | Indefinite | 11 | Nov 1, 2010 | sec.gov |
| Dec 13, 2010 | Amendment | $3,000,000 | $1,195,972 | $1,804,028 | 30 | Feb 24, 2009 | sec.gov |
| Mar 30, 2009 | New notice | $3,000,000 | $282,325 | $2,717,675 | 7 | Feb 4, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Todd B. Creech | Executive Officer | |
| Donald Jeffrey Keyser | Executive Officer, Director | |
| Marc B. Ostro | Director | |
| Guy B. Nohra | Director | |
| Robert B. Truitt | Director | |
| Alvaro F. Guillem | Executive Officer, Director | |
| Cynthia B. Smith | Executive Officer | |
| John B. McKearn | Director | |
| Henrick Sandvad Rasmussen | Executive Officer | |
| Robert B. Alexander | Executive Officer, Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Mar 10, 2014 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what ZS Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.